Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
The Icos Alumni Guide, Trubion CEO Resigns, OVP Leads $30M Fate Deal, & More Seattle-Area Life Sciences News Luke Timmerman 11/19/09 Seattle
Seattle Biotech Needs More Bars, Less University Red Tape, and the Same Daring Attitude, & Other Highlights from Seattle Life Sciences 2029 Luke Timmerman 10/21/09 Seattle
See You Tonight at Seattle Life Sciences 2029 Luke Timmerman 10/19/09 Seattle
The 20-Year Future for Seattle Biotech, As Told By Industry Visionaries, Coming Monday Luke Timmerman 10/15/09 Seattle
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News Luke Timmerman 10/08/09 Seattle
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News Luke Timmerman 10/01/09 Seattle
Recruit Rock Star Scientists To Make Seattle Thrive as an Innovation Hub Carl Weissman 10/01/09 Seattle
From Academics to Biotech: A Journey to the Supposed “Dark Side” Charlotte Hubbert 09/28/09 Seattle
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 2) Luke Timmerman 09/24/09 Seattle
Biotech Pioneer Steve Gillis on Life as a VC, How Today’s Entrepreneurs Can Make It, and Seattle’s Future in Life Sciences (Part 1) Luke Timmerman 09/23/09 Seattle
Lee Hood’s New Idea, Integrative Diagnostics for Early Cancer Detection, Raises $7.5M Luke Timmerman 09/21/09 Seattle
What Will Seattle Biotech Be Like in 20 Years? Xconomy Event Looks Far Into Region’s Future Luke Timmerman 09/10/09 Seattle
Targeted Genetics’ Legacy: No Cures, But a Generation of Seattle Biotechies Luke Timmerman 08/25/09 Seattle
Washington Venture Investing Gravitates to Biotech—The Regional Top 10 List Luke Timmerman 07/21/09 Seattle
OVP Leads $15M Series C Round for Limerick BioPharma Gregory T. Huang 07/15/09 Seattle
Cell Therapeutics Shares Boom, Vulcan’s Breast Cancer Bombshell, Microsoft Buys Rosetta Assets, & More Seattle-Area Life Sciences News Luke Timmerman 06/04/09 Seattle
Can the Feds Get Into the Biotech VC Business? Bionager Wants to Make It Happen Luke Timmerman 05/29/09 Seattle
Dendreon’s Manufacturing Challenge, Archus Cuts Deep, Accelerator Company Launches & More Seattle-Area Life Sciences News Luke Timmerman 05/21/09 Seattle
Ramgen Power Gets $20M, Best Buy Backs Dashwire, WildTangent Teams Up With Mochi, & More Seattle-Area Deals News Gregory T. Huang 05/19/09 Seattle
Xori Gets $2.1M From Accelerator Luke Timmerman 05/15/09 Seattle
Accelerator’s New Startup, Xori, Aims to Use Chicken Cells to Make Better Antibody Drugs Luke Timmerman 05/14/09 Seattle
How Seattle VCs Are Adapting to the UW TechTransfer Revolution (Part 2) Gregory T. Huang 04/17/09 Seattle
OVP Taps Elder Weissman as Adviser Luke Timmerman 03/12/09 Seattle
What Breed is Your Dog? Geneticists From the “Hutch” Pioneered New Test to Provide Answer Luke Timmerman 02/18/09 Seattle
Sticking it to the VC Man: Johnny Stine Builds Biotech Startup on a Shoestring Luke Timmerman 02/06/09 Seattle
Pfizer’s Bid For Wyeth Sends Ripples Through Trubion Pharmaceuticals, Seattle Biotechs Luke Timmerman 01/27/09 Seattle
Seattle Genetics Drug Fights Hodgkin’s, Frazier Sounds Off on Biotech Ventures, SBRI Pushes Malaria Vaccine, & More Seattle-Area Life Sciences News Luke Timmerman 12/11/08 Seattle
OVP Names Carl Weissman Managing Director Luke Timmerman 12/05/08 Seattle
Bruce Carter Exits Stage Left, Targeted Genetics Cuts Payroll, OncoGenex Cancer Drug Prolongs Lives, & More Seattle-Area Life Sciences News Luke Timmerman 12/04/08 Seattle
Traditional Venture Model is “Broken” for Biotech, Companies Need to Adapt, Says VC Alan Frazier Luke Timmerman 12/04/08 Seattle
Page 1 of 2 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.